Close
Nordic 9Nordic 9

Argobio (investor - Others)

Germany
See something wrong or missing? Let us know
Offices:Munich
Average round investment:14.03M USD
Average number per year:2.0
Distribution: 2026 (1)2025 (3)
Portfolio companies: Netherlands Laigo BioFrance Enodia TherapeuticsFrance Elkedonia
Mostly invests in: Netherlands Netherlands (2) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Argobio mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Argobio

Name Criteria
Belgium Theodorus
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Saras Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Invest International
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands LIOF
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Flying Fish Partners
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Captech Santé Nutrition
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Netherlands Rabo Frontier Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
France Wendel
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Belgium Sambrinvest
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Germany Simon Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Top